<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To evaluate the <z:hpo ids='HP_0011009'>acute</z:hpo> effects of colony-stimulating factor (G-CSF) on <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> after <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIALS AND METHODS: Male Wistar rats (10 weeks) received G-CSF (100 μg.kg(-1)) or vehicle </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty minutes later, animals were infarcted by <z:e sem="disease" ids="C0151814" disease_type="Disease or Syndrome" abbrv="">coronary occlusion</z:e> under artificial respiration </plain></SENT>
<SENT sid="3" pm="."><plain>Electrocardiogram was monitored for 30 min to evaluate <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: G-CSF treatment reduced the number of premature ventricular beats and the number and duration of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> was significantly reduced by G-CSF (MI-Cont: 11.2 ± 2.4 vs. MI-GCSF: 5.4 ± 1 events; P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>However, total duration of <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> was not altered (MI-Cont: 84 ± 16 vs. MI-GCSF: 76 ± 13 sec) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0011009'>Acute</z:hpo> administration of G-CSF before coronary ligature in rats reduces the incidence of <z:mp ids='MP_0009732'>ventricular premature beats</z:mp> and <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, suggesting a possible direct electrophysiological effect of this cytokine independently of its genomic effects </plain></SENT>
<SENT sid="8" pm="."><plain>However, the data suggest that G-CSF treatment may affect the spontaneous recovery from <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> G-CSF administration acts directly on cardiac electrophysiology, different from <z:hpo ids='HP_0011010'>chronic</z:hpo> treatment </plain></SENT>
</text></document>